tradingkey.logo
tradingkey.logo
Search

Biontech SE

BNTX
Add to Watchlist
89.330USD
-2.730-2.97%
Close 07-24 16:00ETQuotes delayed by 15 min
22.59BMarket Cap
LossP/E TTM

BNTX Cash Flow Statement

You can access the annual and quarterly cash flow statements of Biontech SE to evaluate its financial soundness and stability.
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
FY2021Q1
FY2020Q4
FY2020Q3
FY2020Q2
FY2020Q1
Operating cash flows (indirect method)
Cash flow from continuing operating activities
44.27%-492.23M
162.33%266.58M
215.39%677.81M
-91.48%126.62M
-134.17%-690.03M
-154.88%-427.71M
-177.59%-587.39M
-62.74%1.49B
52.13%-294.67M
1.47%779.36M
-84.13%757.07M
3.72%3.99B
-116.04%-615.59M
529.50%768.06M
268.38%4.77B
4598.37%3.84B
1595.08%3.84B
-184.04%-178.83M
893.84%1.29B
-546.29%-85.46M
-409.03%-256.66M
--212.79M
---163.11M
---13.22M
---50.42M
Net income from continuing operations
-31.81%-664.22M
-170.44%-195.87M
-85.30%21.44M
52.69%-348.06M
-27.76%-393.67M
-54.22%278.06M
-31.25%145.90M
-96.38%-735.76M
-147.91%-308.14M
-79.33%607.44M
-91.30%212.23M
-116.47%-374.66M
-86.47%643.13M
-30.45%2.94B
-39.42%2.44B
-33.63%2.27B
251.12%4.75B
2307.21%4.23B
2390.23%4.03B
4545.74%3.43B
2851.28%1.35B
--175.53M
---175.82M
---77.10M
---49.21M
Operating gains losses
192.88%141.82M
-7.04%141.95M
164.16%107.83M
-3.25%44.08M
6.36%37.83M
111.56%152.70M
5.90%40.82M
57.14%45.56M
24.65%35.57M
168.69%72.17M
15.28%38.54M
-10.96%28.99M
9.13%28.54M
15.26%26.86M
95.74%33.44M
133.06%32.56M
143.97%26.15M
117.67%23.31M
129.74%17.08M
85.72%13.97M
35.28%10.72M
--10.71M
--7.44M
--7.52M
--7.92M
Other non-cash items
-107.02%-3.39M
1701.40%495.26M
-345.89%-23.96M
-91.39%1.30M
242.10%37.74M
-147.09%-30.93M
151.19%9.75M
104.18%15.07M
-158.34%-26.56M
-91.64%65.67M
-116.42%-19.04M
-6.76%-360.84M
687.80%45.53M
989.73%785.57M
170.72%115.98M
-335.96%-338.01M
107.07%5.78M
-172.05%-88.29M
-2212.94%-164.01M
-135944.04%-77.53M
-32966.14%-81.71M
--122.54M
---7.09M
--57.07K
---247.10K
Change in working capital
115.77%74.95M
69.03%-201.03M
174.62%555.48M
-78.91%454.19M
-281.66%-371.31M
12.37%-649.19M
-225.57%-744.41M
-58.13%2.15B
133.17%204.40M
47.31%-740.80M
-79.41%592.81M
101.48%5.14B
-230.80%-616.14M
-7.47%-1.41B
207.67%2.88B
170.62%2.55B
129.64%471.06M
-1054.37%-1.31B
-435203.20%-2.67B
-7419.75%-3.62B
-9696.99%-1.59B
---113.34M
---614.20K
--49.40M
---16.22M
-Change in receivables
-14.44%504.04M
108.59%69.77M
200.29%765.50M
-123.69%-346.07M
-0.53%460.23M
30.42%-812.32M
-229.57%-763.26M
-68.64%1.46B
-43.04%462.67M
-94.86%-1.17B
-73.72%589.08M
49.55%4.66B
312.47%812.25M
60.98%-599.11M
177.68%2.24B
178.59%3.11B
77.93%-382.28M
-831.77%-1.54B
-7448.82%-2.88B
-60226.71%-3.96B
-91124.38%-1.73B
---164.76M
---38.22M
---6.57M
---1.90M
-Change in inventory
-78.60%8.18M
444.79%100.09M
-86.98%4.43M
307.21%19.71M
161.54%29.87M
-65.42%18.37M
9.79%34.02M
121.47%4.84M
-18.91%11.42M
139.61%53.12M
-57.42%30.98M
-125.09%-22.54M
-65.58%14.09M
-37.15%-134.12M
195.84%72.76M
166.53%89.85M
159.95%40.93M
-132.43%-97.79M
-2287.24%-75.92M
-15718.42%-135.04M
-3418.76%-68.27M
---42.07M
---3.18M
--864.64K
--2.06M
-Change in other current liabilities
39.72%-2.46M
48.64%-5.17M
97.05%-3.65M
-60.08%-9.94M
-42.76%-3.18M
-119.73%-10.06M
-3052.34%-123.56M
78.18%-6.21M
99.66%-2.23M
90.46%-4.58M
---3.92M
---28.45M
---659.49M
---47.98M
----
----
----
----
----
----
----
----
----
----
----
Cash from non-recurring investing activities
Cash from operating activities
44.27%-492.23M
162.33%266.58M
215.39%677.81M
-91.48%126.62M
-134.17%-690.03M
-154.88%-427.71M
-177.59%-587.39M
-62.74%1.49B
52.13%-294.67M
1.47%779.36M
-84.13%757.07M
3.72%3.99B
-116.04%-615.59M
529.50%768.06M
268.38%4.77B
4598.37%3.84B
1595.08%3.84B
-184.04%-178.83M
893.84%1.29B
-546.29%-85.46M
-409.03%-256.66M
--212.79M
---163.11M
---13.22M
---50.42M
Investing cash flow
Net cash from continuing investing activities
-87.07%90.38M
-36.53%52.97M
-59.23%30.99M
-80.08%25.67M
329.36%545.87M
-52.09%83.46M
-46.12%76.03M
-54.17%128.83M
155.29%127.14M
30.34%174.21M
71.99%141.11M
280.12%281.13M
-13.55%49.80M
190.10%133.66M
131.38%82.04M
191.29%73.96M
146.88%57.60M
40.91%46.07M
105.83%35.46M
73.78%25.39M
200.66%23.33M
--32.70M
--17.23M
--14.61M
--7.76M
Capital expenditures
-86.81%92.25M
-35.27%54.44M
-56.08%33.51M
-79.77%26.10M
329.71%546.31M
-51.75%84.10M
-45.92%76.31M
-54.11%129.02M
155.29%127.14M
30.22%174.30M
71.16%141.11M
280.12%281.13M
-13.55%49.80M
179.62%133.85M
131.38%82.44M
188.39%73.96M
139.27%57.60M
41.83%47.87M
106.77%35.63M
75.51%25.65M
210.22%24.07M
--33.75M
--17.23M
--14.61M
--7.76M
Net cash flow from disposal of fixed assets
17.86%64.54M
-11.37%53.92M
-57.02%28.65M
-71.52%22.99M
-21.26%42.78M
-20.64%60.84M
32.26%66.65M
32.15%80.72M
32.26%54.33M
-39.32%76.66M
-34.85%50.40M
-11.80%61.08M
-1.69%41.08M
276.87%126.34M
122.48%77.35M
217.49%69.25M
143.64%41.78M
62.71%33.52M
113.06%34.77M
69.58%21.81M
195.47%17.15M
--20.60M
--16.32M
--12.86M
--5.80M
Net cash flow from intangible asset transactions
-95.99%25.84M
-104.19%-947.46K
-75.00%2.34M
-94.43%2.68M
590.98%503.09M
-76.81%22.62M
-89.66%9.38M
-78.13%48.12M
734.57%72.81M
1233.04%97.55M
1833.75%90.71M
4573.79%220.05M
-44.86%8.72M
-41.69%7.32M
579.68%4.69M
31.57%4.71M
155.87%15.82M
3.77%12.55M
-24.07%690.19K
104.71%3.58M
216.05%6.18M
--12.09M
--909.01K
--1.75M
--1.96M
Net cash flow from business transactions
100.00%0.00
--228.08M
--0.00
--0.00
---69.38M
----
100.00%0.00
----
----
--0.00
---314.42M
----
----
----
----
----
----
64.51%-18.64M
----
----
100.00%0.00
---52.53M
--0.00
--6.31M
---6.01M
Net cash flow from investment products
45.09%3.19B
-492.00%-2.52B
-1314.30%-772.36M
67.25%-29.99M
185.31%1.72B
128.05%643.56M
92.14%-54.61M
94.92%-91.58M
-225.45%-2.01B
-14731.79%-2.29B
-63151.50%-694.45M
-61136.10%-1.80B
-287.49%-618.50M
11.50%-15.47M
99.65%-1.10M
---2.94M
--329.89M
---17.48M
---316.62M
----
----
----
----
----
----
Net cash flow from other investing activities
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
---336.32M
----
----
----
----
----
----
----
Cash from non-current investing activities
Net cash flow from investing activities
119.69%3.10B
-519.15%-2.35B
-514.92%-803.35M
74.75%-55.66M
151.49%1.10B
122.69%560.10M
88.64%-130.64M
89.42%-220.42M
-220.22%-2.14B
-1555.27%-2.47B
-1283.15%-1.15B
-2608.80%-2.08B
-345.44%-668.30M
64.37%-149.13M
76.39%-83.14M
-202.88%-76.90M
1266.99%272.29M
-391.06%-418.52M
-1943.76%-352.08M
-205.88%-25.39M
-69.47%-23.33M
---85.23M
---17.23M
---8.30M
---13.77M
Financing cash flow
Cash flow from continuous financing activities
297.70%30.87M
-82.76%-12.32M
-37.47%-9.98M
45.02%-11.50M
-68.38%-12.20M
42.96%-6.74M
97.50%-7.26M
85.92%-20.91M
97.26%-7.24M
80.28%-11.82M
55.49%-290.25M
80.63%-148.52M
-447.96%-264.72M
-36.72%-59.93M
-14162.64%-652.16M
-688.43%-766.55M
2150.55%76.08M
-144.15%-43.83M
-100.86%-4.57M
4.60%130.27M
-300.20%-3.71M
--99.28M
--533.90M
--124.54M
--1.85M
Net cash flow from debt Issuance/repayment
297.70%30.87M
-57.20%-10.59M
-37.47%-9.98M
45.02%-11.50M
-68.38%-12.20M
39.19%-6.74M
16.32%-7.26M
-144.73%-20.91M
14.29%-7.24M
-32.94%-11.08M
9.42%-8.68M
15.43%-8.54M
70.46%-8.45M
80.98%-8.34M
-109.55%-9.58M
-48.22%-10.10M
-671.19%-28.61M
-218.27%-43.83M
-105.51%-4.57M
-399.15%-6.82M
-300.20%-3.71M
--37.06M
--82.94M
---1.37M
--1.85M
Net cash flow from common stock issuance/repurchase
----
---1.72M
----
----
----
----
100.00%0.00
----
100.00%0.00
98.58%-732.73K
56.18%-281.57M
50.26%-139.97M
-344.79%-256.27M
---51.59M
---642.58M
-305.28%-281.41M
--104.69M
-100.00%0.00
-100.00%0.00
8.88%137.09M
----
--62.22M
--450.96M
--125.91M
--0.00
Cash dividend payments
----
----
----
----
----
----
----
----
----
--0.00
--0.00
-100.00%0.00
----
--0.00
--0.00
--475.04M
----
----
--0.00
----
----
----
----
----
----
Net cash from non-recurrent financing activities
Net cash from financing activities
297.70%30.87M
-82.76%-12.32M
-37.47%-9.98M
45.02%-11.50M
-68.38%-12.20M
42.96%-6.74M
97.50%-7.26M
85.92%-20.91M
97.26%-7.24M
80.28%-11.82M
55.49%-290.25M
80.63%-148.52M
-447.96%-264.72M
-36.72%-59.93M
-14162.64%-652.16M
-688.43%-766.55M
2150.55%76.08M
-144.15%-43.83M
-100.86%-4.57M
4.60%130.27M
-300.20%-3.71M
--99.28M
--533.90M
--124.54M
--1.85M
Net cash flow
Beginning cash balance
-18.75%8.97B
-2.16%8.69B
-6.54%8.92B
7.40%8.80B
-20.34%8.63B
-28.12%8.89B
-27.84%9.54B
-25.74%8.20B
-14.10%10.83B
-0.59%12.36B
41.90%13.22B
82.56%11.04B
686.26%12.61B
479.74%12.43B
1081.43%9.32B
696.01%6.05B
60.73%1.60B
153.66%2.14B
62.46%788.63M
97.44%759.56M
108.45%997.77M
--845.54M
--485.44M
--384.70M
--478.65M
Current period cash flow changes
453.11%2.65B
-1742.75%-2.08B
77.83%-153.33M
-94.28%73.12M
114.98%373.87M
107.55%126.75M
-10.45%-691.46M
-30.46%1.28B
-58.62%-2.50B
-501.34%-1.68B
-115.34%-626.04M
-40.89%1.84B
-137.14%-1.57B
166.64%418.12M
325.55%4.08B
16051.64%3.11B
1712.23%4.24B
-434.48%-627.47M
171.18%959.02M
-81.38%19.26M
-321.88%-262.76M
--187.59M
--353.65M
--103.43M
---62.28M
Effect of exchange rate changes
128.22%9.35M
902.96%11.11M
-152.61%-17.80M
-59.80%13.66M
51.59%-25.90M
-95.16%1.11M
-40.76%33.83M
-59.02%33.97M
-117.20%-53.49M
116.25%22.90M
22.54%57.12M
-24.21%82.89M
-148.59%-24.63M
-1127.27%-140.89M
123.25%46.61M
64282.22%109.37M
142.04%50.69M
134.94%13.71M
24300.70%20.88M
-141.94%-170.40K
39747.72%20.94M
---39.25M
--85.56K
--406.34K
--52.55K
Ending cash balance
0.85%11.62B
-26.64%6.61B
-0.97%8.76B
-6.32%8.88B
7.99%9.00B
-15.64%9.01B
-29.75%8.85B
-26.42%9.47B
-24.46%8.34B
-16.88%10.68B
-5.99%12.60B
40.63%12.88B
88.97%11.04B
747.04%12.85B
666.64%13.40B
1075.66%9.16B
694.54%5.84B
46.86%1.52B
108.28%1.75B
59.55%778.82M
76.53%735.02M
--1.03B
--839.09M
--488.13M
--416.37M
Free cash flow
63.07%-584.48M
141.45%212.14M
197.08%644.30M
-92.59%100.52M
-193.11%-1.24B
-184.59%-511.82M
-207.75%-663.69M
-63.39%1.36B
36.61%-421.81M
-4.60%605.06M
-86.86%615.96M
-1.70%3.71B
-117.60%-665.39M
379.77%634.22M
272.26%4.69B
3493.45%3.77B
1446.35%3.78B
-226.62%-226.69M
798.23%1.26B
-299.15%-111.10M
-382.52%-280.73M
--179.04M
---180.34M
---27.83M
---58.18M
Currency unit
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
Audit opinions
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----

FAQs

What is operating cash flow?

Operating cash flow is the cash generated or used by a company's core business operations. It adjusts net income for non-cash items and working capital changes, such as depreciation, receivables, inventory, and payables. Strong operating cash flow can indicate that the business is converting sales and earnings into real cash.

How Much Operating Cash Flow Did Biontech SE Generate?

Biontech SE generated 529.42M in operating cash flow in fiscal 2025, reflecting cash generated from its core business operations.

How Did Biontech SE's Operating Cash Flow Change Year Over Year?

Biontech SE's operating cash flow increased by 135.32% year over year.

What is investing cash flow?

Investing cash flow shows cash used for or generated from investment-related activities, such as capital expenditures, purchases or sales of investments, acquisitions, and asset disposals. Negative investing cash flow is not always bad, because it can reflect spending on future growth, but investors should check whether those investments support long-term returns.

How Much Does Biontech SE Spend on Capital Expenditures?

Biontech SE spent 869.59M on capital expenditures in the most recent quarter。

What is financing cash flow?

Financing cash flow shows how a company raises capital or returns capital to investors and creditors. It can include debt issuance, debt repayment, share issuance, share repurchases, dividend payments, and lease financing. Positive financing cash flow may show new capital raised, while negative financing cash flow may reflect debt repayment, dividends, or buybacks.

How Has Biontech SE's Financing Cash Flow Changed?

Biontech SE used -61.42M in financing activities in the latest quarter.

What is free cash flow and why does it matter for BNTX?

Free cash flow is the cash a company has left after funding the capital spending needed to maintain or grow the business. It is often used to assess financial flexibility, debt repayment capacity, dividend sustainability, buyback potential, and valuation quality. Investors should compare free cash flow with net income, revenue growth, and capital expenditures.

What was Biontech SE’s free cash flow in the latest quarter?

Free cash flow was -340.17M reflecting a -28.39% change from the previous year.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.